Ziccum AB
Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries liquid biopharmaceuticals, such as vaccines or protein therapeutics into a particle engineered powder product. The company was incorporated in 2017 and is headquartered in Lund, Sweden.
Market Cap & Net Worth: Ziccum AB (ZICC)
Ziccum AB (ST:ZICC) has a market capitalization of $762.89K (Skr8.56 Million) as of March 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #38464 globally and #641 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ziccum AB's stock price Skr0.25 by its total outstanding shares 34232900 (34.23 Million).
Ziccum AB Market Cap History: 2020 to 2025
Ziccum AB's market capitalization history from 2020 to 2025. Data shows change from $82.35 Million to $762.89K (-68.14% CAGR).
Ziccum AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ziccum AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.21x
Ziccum AB's market cap is 6.21 times its annual revenue
2031.04x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $82.35 Million | $5.00K | -$17.34 Million | 16469.61x | N/A |
| 2021 | $31.85 Million | $5.00K | -$21.16 Million | 6369.05x | N/A |
| 2022 | $7.54 Million | $17.00K | -$28.45 Million | 443.28x | N/A |
| 2023 | $23.28 Million | $3.75 Million | -$21.41 Million | 6.21x | N/A |
Competitor Companies of ZICC by Market Capitalization
Companies near Ziccum AB in the global market cap rankings as of March 19, 2026.
Key companies related to Ziccum AB by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Ziccum AB Historical Marketcap From 2020 to 2025
Between 2020 and today, Ziccum AB's market cap moved from $82.35 Million to $ 762.89K, with a yearly change of -68.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | Skr762.89K | -42.53% |
| 2024 | Skr1.33 Million | -94.30% |
| 2023 | Skr23.28 Million | +208.87% |
| 2022 | Skr7.54 Million | -76.34% |
| 2021 | Skr31.85 Million | -61.33% |
| 2020 | Skr82.35 Million | -- |
End of Day Market Cap According to Different Sources
On Jan 30th, 2026 the market cap of Ziccum AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $762.89K USD |
| MoneyControl | $762.89K USD |
| MarketWatch | $762.89K USD |
| marketcap.company | $762.89K USD |
| Reuters | $762.89K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.